Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
EBS · NYSE · Pharmaceutical Preparations
$5.05−0.10 (−1.94%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Emergent Biosolutions (EBS) · oqro.io/stocks/EBS · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Insider trade · Traded Oct 7, 2026 · Filed Oct 7, 2026
Director sold ~$126K of EBS shares in the open marketSourcePlanned sale · Planned for Oct 7, 2026 · Notice filed Oct 7, 2026
Director filed to sell about $126K of EBS stockSourceInsider trade · Traded Oct 1, 2026 · Filed Oct 5, 2026
Officer sold ~$20K of EBS shares in the open marketSourceFederal contract · Signed Apr 10, 2026 · Updated Jun 4, 2026
Department of Health and Human Services awarded Emergent BioSolutions Inc.: $2.8K obligated to dateSourceFederal contract · Signed Apr 28, 2026 · Updated Apr 28, 2026
Department of Health and Human Services awarded Emergent BioSolutions Inc.: $11K obligated to dateSourceFederal contract · Signed Jan 8, 2026 · Updated Mar 4, 2026
Department of Defense awarded Emergent BioSolutions Inc.: $21.5M obligated to dateSourceInsider trade · Traded Aug 15, 2025 · Filed Aug 18, 2025
Director sold ~$63K of EBS shares in the open marketSourceInsider trade · Traded Aug 12, 2025 · Filed Aug 13, 2025
Director sold ~$68K of EBS shares in the open marketSourceInsider trade · Traded May 23, 2025 · Filed May 28, 2025
Director sold ~$49K of EBS shares in the open marketSourceInsider trade · Traded May 13, 2025 · Filed May 15, 2025
CEO purchased ~$350K of EBS shares in the open marketSourceInsider trade · Traded Mar 12, 2025 · Filed Mar 12, 2025
Director sold ~$204K of EBS shares in the open marketSourceInsider trade · Traded Mar 12, 2025 · Filed Mar 12, 2025
Director sold ~$57K of EBS shares in the open marketSourcePolitician trade (House) · Transaction Dec 11, 2024 · Disclosed Jan 10, 2025
Disclosed sale of EBS — reported range $1,001 - $15,000SourceInsider trade · Traded Nov 12, 2024 · Filed Nov 14, 2024
Director sold ~$273K of EBS shares in the open marketSourceInsider trade · Traded Nov 11, 2024 · Filed Nov 13, 2024
Director sold ~$171K of EBS shares in the open marketSource